BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song Y, Li C, Liu G, Liu R, Chen Y, Li W, Cao Z, Zhao B, Lu C, Liu Y. Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes. Clin Pharmacokinet 2021;60:585-601. [PMID: 33723723 DOI: 10.1007/s40262-021-01001-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghiulai R, Mioc M, Racoviceanu R, Prodea A, Milan A, Coricovac D, Dehelean C, Avram Ș, Zamfir AD, Munteanu CVA, Ivan V, Şoica C. Structural Investigation of Betulinic Acid Plasma Metabolites by Tandem Mass Spectrometry. Molecules 2022;27:7359. [DOI: 10.3390/molecules27217359] [Reference Citation Analysis]
2 Xu Y, Tao T, Li S, Tan S, Liu H, Zhu X. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Front Genet 2022;13:975905. [DOI: 10.3389/fgene.2022.975905] [Reference Citation Analysis]
3 Liu L, Liu Y, Zhou X, Xu Z, Zhang Y, Ji L, Hong C, Li C. Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap. Front Pharmacol 2022;13:962718. [DOI: 10.3389/fphar.2022.962718] [Reference Citation Analysis]
4 Mcatee C. Drug-Induced Liver Injury. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.04.007] [Reference Citation Analysis]
5 Lenoir C, Terrier J, Gloor Y, Gosselin P, Daali Y, Combescure C, Desmeules JA, Samer CF, Reny J, Rollason V. Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. JPM 2022;12:526. [DOI: 10.3390/jpm12040526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Calabrò M, Fabbri C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Serretti A, Crisafulli C. Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study. European Neuropsychopharmacology 2022;56:100-11. [DOI: 10.1016/j.euroneuro.2022.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang B, Shi C, Feng L, Pan W, Tian X, Sun C, Wang C, Ning J, Lv X, Wang Y, Yuan Q, Guan R, Zhang H, Ma X, Ma T. Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina. Front Pharmacol 2022;13:856784. [DOI: 10.3389/fphar.2022.856784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cacabelos R, Naidoo V, Corzo L, Cacabelos N, Carril JC. Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. IJMS 2021;22:13302. [DOI: 10.3390/ijms222413302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Martsevich SY, Lukina YV, Drapkina OM. Basic principles of combination therapy: focus on drug-drug interaction. Cardiovasc Ther Prev 2021;20:3031. [DOI: 10.15829/1728-8800-2021-3031] [Reference Citation Analysis]
10 Kumondai M, Gutiérrez Rico EM, Hishinuma E, Nakanishi Y, Yamazaki S, Ueda A, Saito S, Tadaka S, Kinoshita K, Saigusa D, Nakayoshi T, Oda A, Hirasawa N, Hiratsuka M. Functional Characterization of 21 Rare Allelic CYP1A2 Variants Identified in a Population of 4773 Japanese Individuals by Assessing Phenacetin O-Deethylation. J Pers Med 2021;11:690. [PMID: 34442334 DOI: 10.3390/jpm11080690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Danek PJ, Bromek E, Daniel WA. The Influence of Long-Term Treatment with Asenapine on Liver Cytochrome P450 Expression and Activity in the Rat. The Involvement of Different Mechanisms. Pharmaceuticals (Basel) 2021;14:629. [PMID: 34209648 DOI: 10.3390/ph14070629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Li H, Wang YG, Ma ZC, Yun-Hang G, Ling S, Teng-Fei C, Guang-Ping Z, Gao Y. A high-throughput cell-based gaussia luciferase reporter assay for measurement of CYP1A1, CYP2B6, and CYP3A4 induction. Xenobiotica 2021;51:752-63. [PMID: 33896369 DOI: 10.1080/00498254.2021.1918800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]